Rivaroxaban versus low-molecular-weight heparin for venous thromboembolism in gastrointestinal and pancreatobiliary cancer
J. Lee (Seoul, Republic of Korea), J. Lee (Seoul, Republic of Korea)
Source: International Congress 2018 – Diagnosis, prognostication and treatment of pulmonary embolism
Disease area: Pulmonary vascular diseases
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Related content which might interest you: